Earnings History Data for Novo Nordisk A/S (NVO) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Novo Nordisk A/S

Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world's largest producer of industrial enzyme products. The company believes that everyone must care for the environment and our natural resources.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
06-11-2024	PM		NVO	Novo Nordisk A/S	489,600	0.90	0.90	0.73	Novo Nordisk reports Q3 results [11/6/2024 1:58 AM]	105.33	-4.80 (-4.35%)	108.15	-1.98 (-1.80%)	94.73 - 148.15	9,854,035	6,280,000	1,144,675
Novo Nordisk reports Q3 results [11/6/2024 1:58 AM] Novo Nordisk Q3 2024 Earnings Preview [11/5/2024 11:17 AM] Hims & Hers to launch a generic for Novo’s older GLP-1 [11/5/2024 7:23 AM] Novo Nordisk aware of 10 deaths related to weight-loss drug copies - report [11/6/2024 4:41 AM] Novo beats Eli Lilly in Q3 sales for obesity drug [11/6/2024 7:48 AM] Novo Nordisk Posts Solid Earnings. Weight-Loss Drug Wegovy Sales Beat Estimates. [2024-11-06 03:34AM] Novo Nordisk reports 24% sales jump, driven by diabetes and obesity treatments [2024-11-06 02:59AM] Novo Nordisk's sales increased by 23% in Danish kroner and by 24% at constant exchange rates to DKK 204.7 billion in the first nine months of 2024 [2024-11-06 01:41AM] Novo Nordisk Q3 Wegovy sales beat forecast, shares rise [2024-11-06 01:36AM] 2024 election results, Fed meeting, earnings: What to Watch [Nov-05-24 05:15PM] Novo Nordisk Earnings Are Soon. Its All About Weight-Loss Drug Sales. [Nov-05-24 04:30PM] Hims Reports Strong Earnings, Novo Nordisk Copycat Drug Coming in 2025 [Nov-05-24 04:11PM] IBD 50's No. 2 Stock, Hims & Hers, Smashes Estimates On 'Robust' Obesity Trajectory [Nov-05-24 04:07PM] Is Novo Nordisk A/S (NVO) The Best European Stock To Buy According to Hedge Funds? [Nov-05-24 03:18PM] Earnings Exchange: Supermicro, Novo Nordisk, CVS Health [Nov-05-24 02:51PM] Novo Nordisk signs $285m deal with Ascendis to create once-monthly GLP-1RA [Nov-05-24 12:12PM] Hims & Hers will start selling a generic weight loss drug [Nov-05-24 10:50AM] Novo Nordisk Secures License for Ascendis Pharma's Obesity Drug Technology [Nov-05-24 10:00AM] Novo Nordisk A/S - share repurchase programme [Nov-05-24 08:37AM] Catalent misses Q1 revenue estimates ahead of $16.5 billion deal close with Novo Holdings [Nov-05-24 08:25AM] Earnings To Watch: Novo Nordisk AS (OCSE:NOVO B) Reports Q3 2024 Result [Nov-05-24 07:35AM] Ascendis Pharma granted Novo exclusive worldwide license to TransCon platform [Nov-05-24 07:10AM] Allurion boasts over 17% weight loss with swallowable balloon device [Nov-05-24 07:06AM] Microdosing Ozempic? Why some people are playing doctor with weight-loss drugs [Nov-05-24 06:00AM] Novo Nordisk Dips After Tightening Its Outlook As Wegovy Beats, But Ozempic Misses [2024-11-06 08:53AM] Novo Nordisk CFO says 2025 sales could see high-teens percentage growth [2024-11-06 08:40AM] Novo Nordisk Stock Rises on Earnings Beat, Narrowed Outlook [2024-11-06 07:50AM] 5 Things to Know Before the Stock Market Opens [2024-11-06 07:41AM] Novo Nordisk Stock Rises After Earnings. Weight-Loss Drug Wegovy Sales Beat Estimates. [2024-11-06 05:38AM] Novo Nordisk: Q3 Earnings Snapshot [2024-11-06 05:32AM] What can't Ozempic and other weight loss drugs cure? [2024-11-06 05:00AM] Novo Nordisk's Wegovy weight-loss drug sales beat forecast, shares jump [2024-11-06 01:36AM] Novo Nordisk Slumps On Tightened Outlook As Wegovy Beats, But Ozempic Lags [2024-11-06 12:33PM] Top 20 biopharmas market cap rises 2% in Q3 2024 amid flurry of drug approvals [2024-11-06 12:26PM] Strong Wegovy revenue growth for Novo Nordisk but shares dip [2024-11-06 12:21PM] How to play healthcare stocks on Trump's win [2024-11-06 12:04PM] Novo Nordisk, in a mixed-bag earnings report, beat expectations on Wegovy sales but tightened its 2024 outlook [2024-11-06 11:55AM] Novo Nordisk (NVO) Q3 2024 Earnings Call Transcript [2024-11-06 11:45AM] Novo Nordisk Dominates Obesity Market as Wegovy Sales Soar 76% [2024-11-06 11:29AM] Novo Nordisk Q3 earnings: Wegovy sales soar 79% year-over-year [2024-11-06 11:05AM] Wegovy sales are slaying for Novo Nordisk right now [2024-11-06 10:33AM] Novo Nordisk Posts Mixed Results, Adding to Jitters About Weight-Loss Drugs [2024-11-06 09:48AM] Ozempic/Wegovy Maker Maintains Q3 Sales Growth On Booming Demand [2024-11-06 09:39AM] Novo Nordisk Stock Slips as Sales Grow Less Than Expected [2024-11-06 07:50AM]
07-08-2024	PM		NVO	Novo Nordisk A/S	568,890	0.65	0.74	0.63	Novo Nordisk GAAP EPS of DKK 10.17, revenue of DKK 133.41B; raises FY24 outlook [8/7/2024 1:36 AM]	119.27	-10.85 (-8.34%)	122.54	-7.58 (-5.83%)	79.65 - 148.15	12,549,554	4,360,000	585,680
Novo Nordisk GAAP EPS of DKK 10.17, revenue of DKK 133.41B; raises FY24 outlook [8/7/2024 1:36 AM] Novo Nordisk's Wegovy no longer in shortage [8/6/2024 6:21 PM] Novo Nordisk stock falls as Wegovy Q2 sales miss the mark [8/7/2024 9:50 AM]
02-05-2024	PM		NVO	Novo Nordisk A/S	566,170	0.83	0.77	0.63	Novo Nordisk GAAP EPADR of DKK 5.68, revenue of DKK 65.35B; updates FY24 outlook [5/2/2024 1:40 AM]	123.86	-5.35 (-4.14%)	127.54	-1.67 (-1.29%)	75.56 - 138.28	7,159,683	4,060,000	718,204
GLP-1 drug prices falling at UK pharmacies, clinics: report [5/2/2024 9:58 AM] Novo Nordisk says prices dropping for Wegovy, Ozempic: report [5/2/2024 9:17 AM] Novo Nordisk lifts guidance as Ozempic, Wegovy sales surge; but stock falls 3% [5/2/2024 4:11 AM] Novo Nordisk GAAP EPADR of DKK 5.68, revenue of DKK 65.35B; updates FY24 outlook [5/2/2024 1:40 AM]
31-01-2024	PM		NVO	Novo Nordisk	484,968	0.71	0.66	0.00	Novo Nordisk reports Q4 earnings; initiates FY24 outlook [1/31/2024 1:40 AM]	114.87	5.85 (5.37%)	112.37	3.35 (3.07%)	65.58 - 116.12	10,821,431	4,060,000	728,736
Novo Nordisk reports Q4 earnings; initiates FY24 outlook [1/31/2024 1:40 AM] Novo Nordisk FY 2023 Earnings Preview [1/30/2024 11:19 AM] Novo Nordisk stock hits all-time high as Wegovy boosts 2023 results [1/31/2024 5:29 AM] Lilly, Novo could be first trillion-dollar health stocks: world's largest sovereign wealth fund [1/31/2024 12:32 PM]
02-11-2023	PM		NVO	Novo Nordisk A/S	432,440	0.73	0.69	0.43	Novo Nordisk GAAP EPS of DKK 5.00, revenue of DKK 58.73B; raises FY23 sales guidance [11/2/2023 2:41 AM]	100.93	3.25 (3.33%)	100.93	0.0 (0.00%)	54.85 - 104.00	4,847,862	3,480,000	24,636
Novo Nordisk GAAP EPS of DKK 5.00, revenue of DKK 58.73B; raises FY23 sales guidance [11/2/2023 2:41 AM] Novo Nordisk raises outlook buoyed by strong sales of weight loss drug [11/2/2023 5:48 AM] Novo Nordisk says ~80% of insured U.S. patients pay less than $25 for Wegovy [11/2/2023 2:26 PM]
10-08-2023	PM		NVO	Novo Nordisk A/S	363,000	1.26	1.34	0.84	Novo Nordisk GAAP EPS of DKK 8.63, revenue of DKK 54.3B; raises FY23 sales guidance [8/10/2023 3:20 AM]	182.09	-5.50 (-2.93%)	184.73	-2.86 (-1.52%)	95.02 - 192.18	2,733,081	2,180,000	406,558
Novo Nordisk Q2 2023 Earnings Preview [8/9/2023 11:29 AM] Novo Nordisk GAAP EPS of DKK 8.63, revenue of DKK 54.3B; raises FY23 sales guidance [8/10/2023 3:20 AM] Novo Nordisk raises outlook as obesity franchise outperforms in Q2 [8/10/2023 7:12 AM] Novo Nordisk declares DKK 6.00 interim dividend [8/10/2023 9:21 AM] Novo Nordisk to buy Canadian weight loss drug developer Inversago [8/10/2023 12:03 PM]
04-05-2023	PM	0:00 AM ET (May 4)	NVO	Novo Nordisk	378,368	1.27	1.27	0.00	Novo Nordisk GAAP EPS of DKK8.78, revenue of DKK53.37B; updates FY23 outlook [5/4/2023 3:20 AM]	160.45	-7.32 (-4.36%)	162.06	-5.71 (-3.40%)	95.02 - 172.97	2,427,091	1,240,000	181,344
Novo Nordisk stock dips as Wegovy sales miss, drug's US supply hit amid demand [5/4/2023 5:21 AM] Novo Nordisk GAAP EPS of DKK8.78, revenue of DKK53.37B; updates FY23 outlook [5/4/2023 3:20 AM] Novo Nordisk to report Q1 2023 results with Wegovy sales in focus [5/3/2023 1:13 PM]
29-04-2022	PM		NVO	Novo Nordisk	262,702	0.94	0.85	0.00	Novo Nordisk GAAP EPS of DKK6.22, revenue of DKK42.03B [4/29/2022 7:46 AM]	113.73	3.54 (3.21%)	114.42	4.23 (3.84%)	73.53 - 122.16	3,092,975	1,240,000	49,309
Novo Nordisk GAAP EPS of DKK6.22, revenue of DKK42.03B [4/29/2022 7:46 AM] Novo Nordisk once weekly insulin icodec bests Tresiba in lowering blood sugar [4/28/2022 2:24 PM] Novo Nordisk gains after lifting 2022 outlook [4/29/2022 8:43 AM] Novo Nordisk stock rises on Q1 show, raised FY22 sales outlook, boosted buyback [4/29/2022 9:16 AM] Novo Nordisk A/S Total number of voting rights and share capital in Novo Nordisk A/S as of 29 April 2022 [Apr-29-22 07:08AM] UPDATE 1-Earnings, tech rally lift European stocks at end of choppy April [Apr-29-22 05:14AM] Novo Nordisk lifts 2022 outlook after strong quarter, shares jump [Apr-29-22 03:27AM] Novo Nordisk's sales increased by 24% in Danish kroner and by 18% at constant exchange rates to DKK 42.0 billion in the first three months of 2022 [Apr-29-22 02:47AM] Novo Nordisk's sales increased by 24% in Danish kroner and by 18% at constant exchange rates to DKK 42.0 billion in the first three months of 2022 [Apr-29-22 02:39AM] Once-weekly insulin icodec demonstrates superior reduction in HbA1c vs insulin degludec in people with type 2 diabetes in ONWARDS 2 phase 3a trial [Apr-28-22 10:54AM] Here We Go Again: Stock Market Indexes Fade; Meta Platforms Soars, But GPD Falls In Q1 [Apr-28-22 10:36AM] Here We Go Again: Stock Market Indexes Fade; Meta Platforms Soars, But GDP Falls In Q1 [Apr-28-22 10:36AM] 5 Big Pharma, Biotech Stocks Set to Beat Q1 Earnings Estimates [Apr-29-22 07:43AM] UPDATE 2-Miners, earnings lift European stocks at end of choppy April [Apr-29-22 05:14AM] Novo Nordisk (NVO) Q1 2022 Earnings Call Transcript [Apr-29-22 12:30PM]
03-11-2021	PM		NVO	Novo Nordisk	257,709	0.84	0.80	0.00	Novo Nordisk reports Q3 results; updates full year guidance [11/3/2021 8:57 AM]	115.62	5.57 (5.06%)	111.78	1.73 (1.57%)	65.19 - 115.95	1,875,850	820,000	53,551
Novo Nordisk reports Q3 results; updates full year guidance [11/3/2021 8:57 AM] UPDATE 2-After strong quarter, Novo Nordisk urges more competitive US obesity market [Nov-03-21 03:14AM] After strong quarter, Novo Nordisk urges more competitive US obesity market [Nov-03-21 02:43AM] Novo Nordisk's net profit increased by 12% in the first nine months of 2021 [Nov-03-21 02:30AM] 10 Best Diabetes Stocks To Buy Now [Nov-02-21 07:39AM] Novo Nordisk A/S Share repurchase programme [Nov-02-21 06:02AM] Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio [Nov-03-21 10:00AM] Novo Nordisk's (NVO) Q3 Earnings and Sales Beat Estimates [Nov-03-21 01:21PM] Novo Nordisk A/S (NVO) Q3 2021 Earnings Call Transcript [Nov-03-21 06:30PM]
05-05-2021	PM		NVO	Novo Nordisk A/S	170,450	0.88	0.79	0.75	Novo Nordisk EPS beats by $4.62, beats on revenue [5/5/2021 6:49 AM]	74.07	-0.06 (-0.08%)	74.07	0.0 (0.00%)	61.53 - 75.86	1,365,383	810,000	7,223
Novo Nordisk reports Q1 results [5/5/2021 6:49 AM] Novo Nordisk rise 3% on Q1 results; 2021 outlook raised [5/5/2021 7:24 AM] Novo Nordisk boosts 2021 sales, profit growth outlook [5/5/2021 7:52 AM] Novo Nordisk A/S Share repurchase programme [May-04-21 10:38AM] Novo Nordisk ups guidance after Q1 results beat expectations [May-05-21 02:13AM] Novo Nordisk's net profit increased by 6% in the first three months of 2021 [May-05-21 01:30AM] Novo Nordisk lifts guidance after first quarter beats expectations [May-05-21 02:13AM] Novo Nordisk's (NVO) Q1 Earnings and Sales Beat Estimates [May-05-21 09:15AM] Novo Nordisk A/S to Host Earnings Call [May-05-21 10:45AM] Novo Nordisk A/S (NVO) Q1 2021 Earnings Call Transcript [May-05-21 07:30PM]
03-02-2021	PM		NVO	Novo Nordisk A/S	162,740	0.64	0.59	0.55	Novo Nordisk reports Q4 results [2/3/2021 5:25 AM]	72.49	2.00 (2.14%)	72.90	1.93 (2.72%)	49.24 - 73.92	1,301,402	964,755	41,839
Novo Nordisk EPS beats by DKK0.07, beats on revenue [2/3/2021 5:25 AM] Novo Nordisk tops Q4 forecast; shares up 4% [2/3/2021 5:54 AM] Novo Nordisk's (NVO) Q4 Earnings and Sales Beat Estimates [Feb-03-21 08:56AM] Novo Nordisk: Q4 Earnings Insights [Feb-03-21 08:37AM] Diabetes drugmaker Novo Nordisk upbeat on 2021, sees Biden boost [Feb-03-21 04:24AM] Novo Nordisk's net profit increased by 8% in 2020 [Feb-03-21 01:30AM] Novo Nordisk A/S Share repurchase programme [Feb-02-21 09:19AM]
30-10-2020	PM		NVO	Novo Nordisk As	156,712	0.69	0.68	0.00	Novo Nordisk reports Q3 results [10/30/2020 5:18 AM]	63.83	-2.50 (-3.77%)	64.94	-1.38 (-2.09%)	49.24 - 73.81	1,744,881	1,015,855	139,189

06-08-2020	PM	0:00 AM ET (Aug 6)	NVO	Novo Nordisk A/S	152,470	0.67	0.64	0.61	Novo Nordisk EPS beats by DKK0.15, misses on revenue [8/6/2020 4:29 AM]	63.70	-1.39 (-2.14%)	64.09	-1.00 (-1.54%)	48.44 - 68.96	1,000,787	1,049,205	94,255

06-05-2020	PM		NVO	Novo Nordisk A/S	149,090	0.75	0.73	0.66		63.13	-0.49 (-0.77%)	62.90	-0.23 (-0.36%)	46.47 - 65.88	1,884,620	1,241,341	33,352